A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features-Reference-Cited by-同舟云学术

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

Published:2012-01-27 Issue:2 Volume:64 Page:557-567
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Ruperto Nicolino,Quartier Pierre,Wulffraat Nico,Woo Patricia,Ravelli Angelo,Mouy Richard,Bader-Meunier Brigitte,Vastert Sebastiaan J.,Noseda Emanuele,D'Ambrosio Daniele,Lecot Jean,Chakraborty Abhijit,Martini Alberto,Chioato Andrea,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.33342/fullpdf

Reference50 articles.

1. Juvenile idiopathic arthritis;Ravelli;Lancet,2007

2. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?;Ramanan;Rheumatology (Oxford),2005

3. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis;Adams;Curr Opin Rheumatol,2005

4. Systemic onset juvenile rheumatoid arthritis;Schneider;Baillieres Clin Rheumatol,1998

5. Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis;Martini;Lancet,1994

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience;Pediatric Rheumatology;2024-03-19

2. The clinical role of anakinra in the armamentarium against familial Mediterranean fever;Expert Review of Clinical Immunology;2023-12-22

3. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study;Expert Opinion on Biological Therapy;2023-11-17

4. Juvenile idiopathic arthritis and its associated uveitis;Expert Review of Clinical Immunology;2023-07-04

5. Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study;Modern Rheumatology;2022-11-18